Upper-Extremity Deep-Vein Thrombosis: A Retrospective Cohort Evaluation of Thrombotic Risk Factors at a University Teaching Hospital Antithrombosis Clinic

Annals of Pharmacotherapy

Volumn 50, Issue 8, 2016, Pages 637-644

  Stone, Rebecca H ^a   Bress, Adam P ^b   Nutescu, Edith A ^a   Shapiro, Nancy L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

anticoagulation; sickle cell disease; upper extremity deep vein thrombosis

Indexed keywords

HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AFRICAN AMERICAN; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BODY MASS; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; ICD-9; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK FACTOR; SICKLE CELL ANEMIA; TEACHING HOSPITAL; UNIVERSITY HOSPITAL; UPPER EXTREMITY DEEP VEIN THROMBOSIS; ADVERSE EFFECTS; AGED; BLOOD; CHEMICALLY INDUCED; HEMORRHAGE; ILLINOIS; RECURRENT DISEASE; TIME FACTOR;

ADULT; AGED; ANTICOAGULANTS; CENTRAL VENOUS CATHETERS; COHORT STUDIES; FEMALE; HEMORRHAGE; HOSPITALS, TEACHING; HOSPITALS, UNIVERSITY; HUMANS; ILLINOIS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UPPER EXTREMITY DEEP VEIN THROMBOSIS;

EID: 84978476606     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028016649601     Document Type: Article

References (24)

1. C.KearonE.A.AklA.J.Comerota. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2, suppl):e419S-e494S.
2. H.V.JoffeN.KucherV.F.TapsonS.Z.Goldhaber, Deep Vein Thrombosis Free Steering Committee. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation. 2004;110:1605-1611.
3. F.A.SpencerC.EmeryD.LessardR.J.Goldberg; Worcester Venous Thromboembolism Study. Upper extremity deep vein thrombosis: a community-based perspective. Am J Med. 2007;120:678-684.
4. C.MaiD.HuntUpper-extremity deep venous thrombosis: a review. Am J Med. 2011;124:402-407.
5. F.LamontagneL.McIntyreP.Dodek. Nonleg venous thrombosis in critically ill adults: a nested prospective cohort study. JAMA Intern Med. 2014;174:689-696.
6. N.KucherClinical practice: deep-vein thrombosis of the upper extremities. N Engl J Med. 2011;364:861-869.
7. J.D.GrantS.M.StevensS.C.Woller. Diagnosis and management of upper extremity deep-vein thrombosis in adults. Thromb Haemost. 2012;108:1097-1108.
8. M.L.TilneyH.J.GriffithsE.A.EdwardsNatural history of major venous thrombosis of the upper extremity. Arch Surg. 1970;101:792-796.
9. D.LechnerC.WienerA.WeltermannL.EischerS.EichingerP.A.KyrleComparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Haemost. 2008;6:1269-1274.
10. C.A.OwensJ.T.BuiM.G.KnuttinenR.C.GabaT.C.CarrilloPulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. J Vasc Interv Radiol. 2010;21:779-787.
11. E.E.ElmanS.R.KahnThe post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res. 2006;117:609-614.
12. J.A.LeeB.K.ZierlerR.E.ZierlerThe risk factors and clinical outcomes of upper extremity deep vein thrombosis. Vasc Endovasc Surg. 2012;46:139-144.
13. N.IsmaP.J.SvenssonA.GottsaterB.LindbladUpper extremity deep venous thrombosis in the population-based Malmo thrombophilia study (MATS): epidemiology, risk factors, recurrence risk, and mortality. Thromb Res. 2010;125:e335-338.
14. S.Lavau-DenesP.LacroixA.Maubon. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study. Cancer Chemother Pharmacol. 2013;72:65-73.
15. R.P.NaikM.B.StreiffC.HaywoodJrJ.B.SegalS.LanzkronVenous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease. J Thromb Haemost. 2014;12:2010-2016.
16. T.W.BucknerN.S.KeyVenous thrombosis in blacks. Circulation. 2012;125:837-839.
17. R.P.NaikM.B.StreiffC.HaywoodJrJ.A.NelsonS.LanzkronVenous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication. Am J Med. 2013;126:443-449.
18. S.R.KahnW.LimA.S.Dunn. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2, Suppl):e195S-226S.
19. W.H.GeertsD.BergqvistG.F.Pineo. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6, suppl):381S-453S.
20. National Quality Measures Clearinghouse. Percent time in therapeutic INR range (TTR): mean TTR achieved among patients who received prescriptions for warfarin and had sufficient INR values to calculate TTR. https://www.qualitymeasures.ahrq.gov/content.aspx?id=32739. Accessed March 28, 2016.
21. S.SchulmanC.Kearon; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692-694.
22. R.P.NaikM.B.StreiffS.LanzkronSickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know. J Thromb Thrombolysis. 2013;35:352-358.
23. E.A.NutescuA.BautistaW.Gao. Warfarin anticoagulation after total hip or total knee replacement: clinical and resource-utilization outcomes in a university-based antithrombosis clinic. Am J Health Syst Pharm. 2013;70:423-430.
24. CoaguChek XS Plus. http://www.coaguchek.com/coaguchek_hcp/en/home/products/xs_plus_system.html. Accessed April 28, 2016.